These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3940623)

  • 41. Response to chemotherapy and treating institution predict survival in primary central nervous system lymphoma.
    Korfel A; Martus P; Nowrousian MR; Hossfeld DK; Kirchen H; Brücher J; Stelljes M; Birkmann J; Peschel C; Pasold R; Fischer L; Jahnke K; Thiel E;
    Br J Haematol; 2005 Jan; 128(2):177-83. PubMed ID: 15638851
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Primary Oculocerebral Lymphoma: MTX Polychemotherapy Alone on Intraocular Disease Control.
    Nguyen DT; Houillier C; Choquet S; Cassoux N; Soussain C; Le Cossec C; Legarf-Tavernier M; Costopoulos M; LeHoang P; Bodaghi B; Omuro A; Hoang-Xuan K; Touitou V
    Ophthalmology; 2016 Sep; 123(9):2047-50. PubMed ID: 27137876
    [No Abstract]   [Full Text] [Related]  

  • 43. [Long-term results of 2 therapeutic protocols in children with acute lymphoblastic leukemia of usual risk. Experience at the 20th of November National Medical Center].
    López-Hernández MA; de Diego Flores-Chapa J; Borbolla-Escoboza JR; Trueba-Christy E; Carrillo-Rosales T; González-Avante M
    Gac Med Mex; 1998; 134(2):145-51. PubMed ID: 9618993
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial.
    Thiel E; Korfel A; Martus P; Kanz L; Griesinger F; Rauch M; Röth A; Hertenstein B; von Toll T; Hundsberger T; Mergenthaler HG; Leithäuser M; Birnbaum T; Fischer L; Jahnke K; Herrlinger U; Plasswilm L; Nägele T; Pietsch T; Bamberg M; Weller M
    Lancet Oncol; 2010 Nov; 11(11):1036-47. PubMed ID: 20970380
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacotherapy of primary CNS lymphoma.
    Park DM; Abrey LE
    Expert Opin Pharmacother; 2002 Jan; 3(1):39-49. PubMed ID: 11772332
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chemotherapy of primary malignant brain tumors in children.
    Shapiro WR
    Cancer; 1975 Mar; 35(3 suppl):965-72. PubMed ID: 1111955
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Primary lymphoma of bone in children: analysis of treatment results with adriamycin, prednisone, Oncovin (APO), and local radiation therapy.
    Loeffler JS; Tarbell NJ; Kozakewich H; Cassady JR; Weinstein HJ
    J Clin Oncol; 1986 Apr; 4(4):496-501. PubMed ID: 3958763
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Primary hepatic lymphoma in an adolescent treated with hepatic lobectomy and chemotherapy.
    Pescovitz MD; Snover DC; Orchard P; Neglia JP; Najarian JS; Payne WD
    Cancer; 1990 May; 65(10):2222-6. PubMed ID: 2346906
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Non-Hodgkin's lymphoma in children. Study of 30 patients at the Caracas University Hospital].
    Acquatella G; Urdaneta N; Rosas Uribe A; García Guevara R
    Sangre (Barc); 1985; 30(3):253-83. PubMed ID: 3839940
    [No Abstract]   [Full Text] [Related]  

  • 50. [Chemotherapy of primary cerebral lymphoma].
    Delwail V; Bataille B
    Neurochirurgie; 1997; 43(6):380-4. PubMed ID: 9706617
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparing the Efficacy of DeVIC Therapy and High-dose Methotrexate Monotherapy with Whole-brain Radiation Therapy for Newly-diagnosed Primary Central Nervous System Lymphoma: A Single Institution Study.
    Chalise L; Motomura K; Ohka F; Hirano M; Hara M; Nishimura Y; Natsume A; Wakabayashi T
    Anticancer Res; 2017 Sep; 37(9):5215-5223. PubMed ID: 28870957
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pulses of vincristine and dexamethasone in addition to intensive chemotherapy for children with intermediate-risk acute lymphoblastic leukaemia: a multicentre randomised trial.
    Conter V; Valsecchi MG; Silvestri D; Campbell M; Dibar E; Magyarosy E; Gadner H; Stary J; Benoit Y; Zimmermann M; Reiter A; Riehm H; Masera G; Schrappe M
    Lancet; 2007 Jan; 369(9556):123-31. PubMed ID: 17223475
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Local methotrexate and dexamethasone phosphate for the treatment of recurrent primary intraocular lymphoma.
    Velez G; Boldt HC; Whitcup SM; Nussenblatt RB; Robinson MR
    Ophthalmic Surg Lasers; 2002; 33(4):329-33. PubMed ID: 12134997
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cyclophosphamide, doxorubicin, vincristine, and dexamethasone in primary lymphoma of the brain: a case report.
    Stewart DJ; Russell N; Atack EA; Quarrington A; Stolbach L
    Cancer Treat Rep; 1983 Mar; 67(3):287-91. PubMed ID: 6831476
    [No Abstract]   [Full Text] [Related]  

  • 55. Intensified and high-dose chemotherapy with granulocyte colony-stimulating factor and autologous stem-cell transplantation support as first-line therapy in high-risk diffuse large-cell lymphoma.
    Vitolo U; Cortellazzo S; Liberati AM; Freilone R; Falda M; Bertini M; Botto B; Cinieri S; Levis A; Locatelli F; Lovisone E; Marmont F; Pizzuti M; Rossi A; Viero P; Barbui T; Grignani F; Resegotti L
    J Clin Oncol; 1997 Feb; 15(2):491-8. PubMed ID: 9053470
    [TBL] [Abstract][Full Text] [Related]  

  • 56. 5-year survey of methotrexate, cyclophosphamide (Endoxan), and vincristine (MEV) therapy for advanced non-Hodgkin's lymphomas.
    Lauria F; Baccarani M; Fiacchini M; Frezza R; Gobbi M; Tura S
    Cancer Treat Rep; 1978 Aug; 62(8):1193-7. PubMed ID: 688255
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dexamethasone, carmustine, etoposide, cytarabine, and melphalan (dexa-BEAM) followed by high-dose chemotherapy and stem cell rescue--a highly effective regimen for patients with refractory or relapsed indolent lymphoma.
    Josting A; Reiser M; Wickramanayake PD; Rueffer U; Draube A; Söhngen D; Tesch H; Wolf J; Diehl V; Engert A
    Leuk Lymphoma; 2000 Mar; 37(1-2):115-23. PubMed ID: 10721775
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Case of central nervous system lymphoma metastasized to breast after remission by methotrexate chemotherapy].
    Ohta M; Takeshita I; Matsumoto K; Matsuoka S; Ikeda K
    No Shinkei Geka; 2005 Mar; 33(3):263-8. PubMed ID: 15773316
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MGMT promoter methylation status and prognosis of patients with primary or recurrent glioblastoma treated with carmustine wafers.
    Gutenberg A; Bock HC; Brück W; Doerner L; Mehdorn HM; Roggendorf W; Westphal M; Felsberg J; Reifenberger G; Giese A
    Br J Neurosurg; 2013 Dec; 27(6):772-8. PubMed ID: 23662801
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dose-Adjusted EPOCH-R and Mid-Cycle High Dose Methotrexate for Patients with Systemic Lymphoma and secondary CNS Involvement.
    Chihara D; Fowler NH; Oki Y; Fanale MA; Fayad LE; Westin JR; Hagemeister FB
    Br J Haematol; 2017 Dec; 179(5):851-854. PubMed ID: 27502933
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.